Portrait_default
country
Sex: F
Data Quality: 0 stars
Parkinson's: 12 yrs
Hoehn-Yahr 3 Type: Parkinson's disease
Mouth/throat: mild
Arms: mild
Chest: none
Legs: mild
country
Female, 79 years
La Center, KY
Primary Condition
Parkinson's
Type
Parkinson's disease
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

country's Carbidopa-Levodopa CR is for:

country's side effects of Carbidopa-Levodopa CR:

country's Carbidopa-Levodopa CR History (Ongoing)
5 x 25 mg-100 mg Daily Jan 20, 2008 - Last Update
Evaluations
Date Dosage legible handwriting Perceived effectiveness Improve mobility Perceived effectiveness Stiffness/Spasticity Perceived effectiveness Side Effects Adherence Burden
Jan 29, 2010 5 x 25 mg-100 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default MildMildMildMild UsuallyUsuallyUsuallyUsually SomewhatSomewhatSomewhatSomewhat
Date
Jan 29, 2010
Advice & Tips
I am presently taking 1/2 tab of 50/200 carbidopa/levadopaCR 5 times a day. This dose has improved my balance, walking and handwriting, while moderating the dyskenesia. It does seem like I am watching the clock a lot
Cost
< $25 monthly

About Carbidopa-Levodopa CR (Prescription Drug)

A controlled release preparation of carbidopa/levodopa formulated to release a lower, smoother dose of medication. It is sometimes taken last thing at night in order to maintain dopamine levels throughout sleep and into the morning.

Learn more about Carbidopa-Levodopa CR in our Carbidopa-Levodopa CR Community Report.

Back to country's Profile